Stock ACOR ACORDA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Acorda Therapeutics, Inc. Nasdaq

Equities

ACOR

US00484M7002

Market Closed - Nasdaq
Other stock markets
 03:44:08 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.395 USD -14.13% Intraday chart for Acorda Therapeutics, Inc. -47.33% -97.38%
May. 14 Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 10 Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acorda: Q1 Earnings Snapshot
AQ
Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc.
CI
Final DIP Financing Approved for Acorda Therapeutics, Inc.
CI
Bidding Procedure Approved for Acorda Therapeutics, Inc.
CI
Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market
MT
Acorda Therapeutics Announces Delisting from Nasdaq
BU
Interim DIP Financing Approved for Acorda Therapeutics, Inc.
CI
Acorda Therapeutics, Inc.(OTCPK:ACOR.Q) dropped from S&P TMI Index
CI
Merz Pharmaceuticals, LLC entered into an asset purchase agreement to acquire Substantially all of the Companys assets of Acorda Therapeutics, Inc. for approximately $190 million.
CI
Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACOR.Q Stock
  4. ACOR Stock
  5. News Acorda Therapeutics, Inc.